| Year |
Citation |
Score |
| 2024 |
Yang X, Mao Q, Wang B. On the Question of CO's Ability to Induce HO-1 Expression in Cell Culture: A Comparative Study Using Different CO Sources. Acs Chemical Biology. PMID 38340055 DOI: 10.1021/acschembio.3c00750 |
0.485 |
|
| 2023 |
Bauer N, Yuan Z, Yang X, Wang B. Plight of CORMs: the unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology. Biochemical Pharmacology. 115642. PMID 37321416 DOI: 10.1016/j.bcp.2023.115642 |
0.496 |
|
| 2023 |
Yu B, Yang X, Yuan Z, Wang B. Prodrugs of sulfide and persulfide species: Implications in their different pharmacological activities. Current Opinion in Chemical Biology. 75: 102329. PMID 37279623 DOI: 10.1016/j.cbpa.2023.102329 |
0.712 |
|
| 2023 |
Liu D, Yang X, Wang B. Sensing a CO-Releasing Molecule (CORM) Does Not Equate to Sensing CO: The Case of DPHP and CORM-3. Analytical Chemistry. PMID 37263968 DOI: 10.1021/acs.analchem.3c01495 |
0.444 |
|
| 2023 |
Bauer N, Yang X, Yuan Z, Wang B. Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor. Chemical Science. 14: 3215-3228. PMID 36970102 DOI: 10.1039/d3sc00411b |
0.465 |
|
| 2023 |
Yang X, Tripathi R, Wang M, Lu W, Anifowose A, Tan C, Wang B. Toward "CO in a Pill": Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via Gastrointestinal CO Release. Molecular Pharmaceutics. PMID 36802675 DOI: 10.1021/acs.molpharmaceut.2c01104 |
0.783 |
|
| 2022 |
Yang X, Yuan Z, Lu W, Yang C, Wang M, Tripathi R, Fultz Z, Tan C, Wang B. De Novo Construction of Fluorophores via CO Insertion-Initiated Lactamization: A Chemical Strategy toward Highly Sensitive and Highly Selective Turn-On Fluorescent Probes for Carbon Monoxide. Journal of the American Chemical Society. PMID 36548940 DOI: 10.1021/jacs.2c07504 |
0.583 |
|
| 2022 |
Dong R, Yang X, Wang B, Ji X. Mutual leveraging of proximity effects and click chemistry in chemical biology. Medicinal Research Reviews. PMID 36177531 DOI: 10.1002/med.21927 |
0.71 |
|
| 2022 |
Tripathi R, Anifowose A, Lu W, Yang X, Wang B. Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core. Journal of Enzyme Inhibition and Medicinal Chemistry. 37: 2370-2381. PMID 36043494 DOI: 10.1080/14756366.2022.2116699 |
0.776 |
|
| 2022 |
Yu B, Roy Choudhury M, Yang X, Benoit SL, Womack E, Van Mouwerik Lyles K, Acharya A, Kumar A, Yang C, Pavlova A, Zhu M, Yuan Z, Gumbart JC, Boykin DW, Maier RJ, et al. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants. Acs Infectious Diseases. PMID 35801980 DOI: 10.1021/acsinfecdis.2c00121 |
0.728 |
|
| 2022 |
De La Cruz LK, Bauer N, Cachuela A, Tam WS, Tripathi R, Yang X, Wang B. Light-Activated CO Donor as a Universal CO Surrogate for Pd-Catalyzed and Light-Mediated Carbonylation. Organic Letters. 24: 4902-4907. PMID 35786951 DOI: 10.1021/acs.orglett.2c01726 |
0.448 |
|
| 2022 |
Yuan Z, De La Cruz LK, Yang X, Wang B. Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response. Pharmacological Reviews. 74: 823-873. PMID 35738683 DOI: 10.1124/pharmrev.121.000564 |
0.463 |
|
| 2022 |
Lu W, Yang X, Wang B. Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities. Biochemical Pharmacology. 200: 115041. PMID 35447132 DOI: 10.1016/j.bcp.2022.115041 |
0.604 |
|
| 2022 |
Yang X, Lu W, Wang M, De La Cruz LK, Tan C, Wang B. Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill. International Journal of Pharmaceutics. 618: 121650. PMID 35276229 DOI: 10.1016/j.ijpharm.2022.121650 |
0.635 |
|
| 2021 |
Tripathi R, Yang X, Ryter SW, Wang B. Carbon Monoxide as a Therapeutic for Airway Diseases: Contrast and Comparison of Various CO Delivery Modalities. Current Topics in Medicinal Chemistry. PMID 34784868 DOI: 10.2174/1568026621666211116090917 |
0.487 |
|
| 2021 |
Yuan Z, Yang X, Wang B. Redox and catalase-like activities of four widely used carbon monoxide releasing molecules (CO-RMs). Chemical Science. 12: 13013-13020. PMID 34745532 DOI: 10.1039/d1sc03832j |
0.522 |
|
| 2021 |
Yang X, Lu W, Wang M, Tan C, Wang B. "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34481027 DOI: 10.1016/j.jconrel.2021.08.059 |
0.616 |
|
| 2021 |
De La Cruz LK, Yang X, Menshikh A, Brewer M, Lu W, Wang M, Wang S, Ji X, Cachuela A, Yang H, Gallo D, Tan C, Otterbein L, de Caestecker M, Wang B. Adapting decarbonylation chemistry for the development of prodrugs capable of delivery of carbon monoxide utilizing sweeteners as carrier molecules. Chemical Science. 12: 10649-10654. PMID 34447558 DOI: 10.1039/d1sc02711e |
0.772 |
|
| 2021 |
De La Cruz LK, Ji X, Yang X, Wang B. Click, release, and fluoresce: In-vivo generation of CO with concomitant synthesis of a fluorescent reporter. Bioorganic & Medicinal Chemistry. 44: 116297. PMID 34243045 DOI: 10.1016/j.bmc.2021.116297 |
0.736 |
|
| 2021 |
Yang X, Lu W, Hopper CP, Ke B, Wang B. Nature's marvels endowed in gaseous molecules I: Carbon monoxide and its physiological and therapeutic roles. Acta Pharmaceutica Sinica. B. 11: 1434-1445. PMID 34221861 DOI: 10.1016/j.apsb.2020.10.010 |
0.72 |
|
| 2021 |
Bhattarai N, Wang J, Nguyen D, Yang X, Helmers L, Paruch J, Li L, Zhang Y, Meng K, Wang A, Jayawickramarajah J, Wang B, Zeng S, Lu H. Nanoparticle encapsulation of non-genotoxic p53 activator Inauhzin-C for improved therapeutic efficacy. Theranostics. 11: 7005-7017. PMID 34093867 DOI: 10.7150/thno.57404 |
0.442 |
|
| 2021 |
Yuan Z, Yang X, Ye Y, Tripathi R, Wang B. Chemical Reactivities of Two Widely Used Ruthenium-Based CO-Releasing Molecules with a Range of Biologically Important Reagents and Molecules. Analytical Chemistry. PMID 33745269 DOI: 10.1021/acs.analchem.1c00533 |
0.487 |
|
| 2021 |
Bakalarz D, Surmiak M, Yang X, Wójcik D, Korbut E, Śliwowski Z, Ginter G, Buszewicz G, Brzozowski T, Cieszkowski J, Głowacka U, Magierowska K, Pan Z, Wang B, Magierowski M. Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage. Acta Pharmaceutica Sinica. B. 11: 456-475. PMID 33643824 DOI: 10.1016/J.Apsb.2020.08.005 |
0.692 |
|
| 2020 |
Yang X, Pan Z, Choudhury MR, Yuan Z, Anifowose A, Yu B, Wang W, Wang B. Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery. Medicinal Research Reviews. PMID 32803765 DOI: 10.1002/Med.21720 |
0.745 |
|
| 2020 |
Wang M, Yang X, Pan Z, Wang Y, De La Cruz LK, Wang B, Tan C. Towards "CO in a pill": Pharmacokinetic studies of carbon monoxide prodrugs in mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32745568 DOI: 10.1016/J.Jconrel.2020.07.040 |
0.763 |
|
| 2020 |
Anifowose A, Agbowuro AA, Tripathi R, Lu W, Tan C, Yang X, Wang B. Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs. Medicinal Chemistry Research : An International Journal For Rapid Communications On Design and Mechanisms of Action of Biologically Active Agents. 29: 1199-1210. PMID 32719577 DOI: 10.1007/S00044-020-02563-Y |
0.778 |
|
| 2020 |
Yang XX, Ke BW, Lu W, Wang BH. CO as a therapeutic agent: discovery and delivery forms. Chinese Journal of Natural Medicines. 18: 284-295. PMID 32402406 DOI: 10.1016/S1875-5364(20)30036-4 |
0.738 |
|
| 2020 |
Wang B, Yu B, Yuan Z, Yang X. Prodrugs of Persulfides, SO2, and CS2: Important Tools for Studying Sulfur Signaling at Various Oxidation States. Antioxidants & Redox Signaling. PMID 32041416 DOI: 10.1089/Ars.2019.7880 |
0.723 |
|
| 2020 |
Yuan Z, Yang X, De La Cruz LK, Wang B. Nitro reduction-based fluorescent probes for carbon monoxide require reactivity involving a ruthenium carbonyl moiety. Chemical Communications (Cambridge, England). PMID 31971171 DOI: 10.1039/C9Cc08296D |
0.508 |
|
| 2020 |
Anifowose A, Agbowuro AA, Yang X, Wang B. Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2 Medicinal Chemistry Research. 29: 1105-1121. DOI: 10.1007/S00044-020-02574-9 |
0.777 |
|
| 2019 |
Yang X, de Caestecker M, Otterbein LE, Wang B. Carbon monoxide: An emerging therapy for acute kidney injury. Medicinal Research Reviews. PMID 31820474 DOI: 10.1002/Med.21650 |
0.501 |
|
| 2019 |
Anifowose A, Yuan Z, Yang X, Pan Z, Zheng Y, Zhang Z, Wang B. Upregulation of p53 through induction of MDM2 degradation: Amino acid prodrugs of anthraquinone analogs. Bioorganic & Medicinal Chemistry Letters. 126786. PMID 31753697 DOI: 10.1016/J.Bmcl.2019.126786 |
0.746 |
|
| 2019 |
Draganov AB, Yang X, Anifowose A, De La Cruz LKC, Dai C, Ni N, Chen W, De Los Santos Z, Gu L, Zhou M, Wang B. Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs. Bioorganic & Medicinal Chemistry. PMID 31324563 DOI: 10.1016/J.Bmc.2019.07.019 |
0.729 |
|
| 2019 |
Ji X, Aghoghovbia RE, De La Cruz LKC, Pan Z, Yang X, Yu B, Wang B. Click and Release: A High-Content Bioorthogonal Prodrug with Multiple Outputs. Organic Letters. PMID 31063383 DOI: 10.1021/Acs.Orglett.9B01086 |
0.718 |
|
| 2018 |
Yuan Z, Zheng Y, Yu B, Wang S, Yang X, Wang B. Esterase-Sensitive Glutathione Persulfide Donor. Organic Letters. PMID 30299967 DOI: 10.1021/Acs.Orglett.8B02611 |
0.748 |
|
| 2013 |
Yang X, Lin H, Lu W, Wang D. Compatibility study of Merrifield linker in Fmoc strategy peptide synthesis. Protein and Peptide Letters. 20: 140-5. PMID 22894150 |
0.383 |
|
| Show low-probability matches. |